Co-beneldopa (Benserazide/levodopa) vs Botulinum toxin type A

National NHS prescribing compared (Prescription Cost Analysis)

Data updated March 2026

Co-beneldopa (Benserazide/levodopa) was dispensed 3,970.7× as often as Botulinum toxin type A in March 2026 — 79,414 items versus 20 in England.

79,414items

Co-beneldopa (Benserazide/levodopa) · March 2026

NHSBSA Prescription Cost Analysis

20items

Botulinum toxin type A · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Co-beneldopa (Benserazide/levodopa) versus Botulinum toxin type A: national items dispensed by month

▬ Co-beneldopa (Benserazide/levodopa) · ╌ Botulinum toxin type A

Source: NHSBSA Prescription Cost Analysis, to March 2026

Co-beneldopa (Benserazide/levodopa) versus Botulinum toxin type A, March 2026
Measure	Co-beneldopa (Benserazide/levodopa)	Botulinum toxin type A
Items, March 2026	79,414	20
Items, last 12 months	949,699	207
Net ingredient cost, March 2026	£886,111	£5,729